SNPX Synaptogenix Inc. Sof moliyaviy natija

Synaptogenix (SNPX) kompaniyasining rasmiy ramzlari

Demensiya terapiyasiga bo'lgan talab bozor sikllaridan mustaqil bo'lib, bu biznes barqarorligini ta'minlaydi. Synaptogenix, Inc. (SNPX) Altsgeymer kasalligiga qarshi kurashish uchun innovatsion regenerativ molekulalarni ishlab chiqmoqda. Ushbu grafikdagi kompaniyaning operatsion foydasi daromadning yo'qligini aks ettiradi, bunda 0.00 darajasi muhim mezon bo'lib xizmat qiladi. Joriy moliyaviy holat tijoriy ishlab chiqarishdan oldingi tadqiqot xarajatlari natijasida yuzaga kelgan naqd pul yetishmovchiligi bilan tavsiflanadi.

Kompaniyaning sof foydasi: synaptogen.com (SNPX) 04.07.2022 - 02.05.2026 uchun

Synaptogenix (SNPX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Synaptogenix, Inc|SNPX - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Synaptogenix, Inc|SNPX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
Bitta aksiya hisobiga sof aktivlar qiymati Synaptogenix|SNPX - Kompaniyaning balans qiymati|Kapitallashuvning balans qiymatiga nisbati synaptogen.com|SNPX - Kompaniyaning umumiy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Synaptogenix, Inc.|SNPX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Synaptogenix Inc.|SNPX - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Synaptogenix, Inc|SNPX - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Synaptogenix|Kritik likvidlik synaptogen.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
SNPX - Sof foyda
Kompaniyaning jamlanma tahlili:Synaptogenix, Inc - SNPX
synaptogen.com ishlab chiqargan mahsulot

Investorlar biznesning ijobiy pul oqimini yaratish qobiliyatini tahlil qilish orqali kapital uchun fundamental xavflarni baholaydilar. Tashqi moliyalashtirish va Altsgeymer kasalligiga qarshi dori vositalarining klinik sinovlari natijalariga tayanadigan Synaptogenix, Inc. (SNPX) uchun kompaniyaning joriy sof foydasi sof foydning bir birligiga to'g'ri keladigan bozor kapitalizatsiyasini vizuallashtiradi, bu esa qiymat yaratilishining haqiqiy sur'atini va terapiya muvaffaqiyatsiz bo'lgan taqdirda likvidlik yo'qolishi xavflarini aniqlash imkonini beradi.

Asosiy raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|regencellbioscience.com (RGC) - Sof moliyaviy natija|Sof daromad AXSM (Axsome Therapeutics, Inc.)|ACAD - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|VKTX: Kompaniya foydasi|Supernus Pharmaceuticals - Sof foyda|CPRX - Sof foyda|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda HRMY (Harmony Biosciences Inc)|Sof daromad BHVN|AMLX (Amylyx Corp) - Soliqlar to‘langandan keyingi foyda|Kompaniyaning sof foydasi Trevi Therapeutics (TRVI)|PRAX - Kompaniyaning sof daromadi|Sof foyda AVXL (Anavex Life Sciences Corp.)|Yillik sof foyda CeriBell Inc|Prothena Biosciences - Sof foyda|Kompaniyaning sof daromadi Alector, Inc.|Annexon, Inc. (ANNX) - Kompaniyaning sof foydasi|Kompaniya foydasi OMER|NGNE (Neurogene) - Sof foyda|AC Immune S.A. (ACIU) - Sof moliyaviy natija|Sof daromad VYGR (Voyager Pharma)|Neumora Corp - Kompaniya foydasi|Scilex Holding Company - Sof daromad|Yakuniy foyda TVGN|Alpha Cognition Corp - Sof foyda|Sof moliyaviy natija cogrx.com CGTX|Inhibikase (IKT) - Kompaniyaning sof foydasi|Kompaniya foydasi SAVA|ASRT (Assertio Holdings) - Sof foyda|Sof daromad Coya (COYA)|Sof daromad VTGN (Vistagen Therapeutics)|Sof moliyaviy natija ovidrx.com|Kompaniyaning sof foydasi Acumen Pharma ABOS|Sof moliyaviy natija CervoMed Corporation (CRVO)|ATHE - Kompaniyaning sof foydasi|CLNN (Clene Inc.) - Kompaniya foydasi|pepgen.com (PEPG) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda JUNS (jupiterneurosciences.com)|Sof daromad RLMD|Kompaniya foydasi ANVS (Annovis Bio Corporation)|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|fireflyneuro.com - Kompaniya foydasi|Sof foyda KLTO (Klotho Neurosciences)|NeuroSense Therapeutics Ltd (NRSN) - Kompaniyaning sof daromadi|RVPH: Sof daromad|MTVA - Sof foyda|NeurAxis, Inc. (NRXS) - Kompaniyaning sof foydasi|Helius Medical Technologies - Yakuniy foyda|Kompaniyaning sof foydasi Passage Bio Inc.|Kompaniyaning sof daromadi Neuphoria NEUP|Kompaniyaning sof foydasi Minerva Neurosciences Corp (NERV)|Sof moliyaviy natija Athira Pharma Corp|Addex Therapeutics - Sof daromad|Alzamend Neuro Inc. (ALZN) - Kompaniyaning sof daromadi|CYCN - Kompaniyaning sof foydasi|PTIX (Protagenic Therapeutics) - Kompaniya foydasi|KTTA: Sof foyda|Cortigent (CRGT) - Sof foyda|Kompaniyaning sof foydasi Avenue Therapeutics|brainstorm-cell.com - Soliqdan keyingi foyda|Sof daromad CARA (Cara Therapeutics)|Soliqlar to‘langandan keyingi foyda CHRO|Kompaniyaning sof foydasi Eliem Therapeutics Inc. ELYM|Intra-Cellular Therapies Inc. (ITCI) - Kompaniyaning sof daromadi|Longboard Pharmaceuticals - Sof foyda|Yillik sof foyda marinuspharma.com (MRNS)|NKGN: Sof foyda|Kompaniyaning sof daromadi NeuroBo Pharmaceuticals Inc (NRBO)|Kompaniyaning sof foydasi Sage Therapeutics, Inc|Kompaniya foydasi TRVN (Trevena Inc)|Sof foyda VIGL|Sof moliyaviy natija Anew Medical Inc.|Cerevel Therapeutics, Inc. - Sof daromad